TLX Annual CAPEX
$7.17 M
-$2.46 M-25.57%
01 December 2023
Summary:
As of January 21, 2025, TLX annual capital expenditures is $7.17 million, with the most recent change of -$2.46 million (-25.57%) on December 1, 2023. During the last 3 years, it has risen by +$6.94 million (+3120.63%). TLX annual CAPEX is now -25.57% below its all-time high of $9.63 million, reached on December 1, 2022.TLX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.6% | - | - |
| 3 y3 years | +3120.6% | - | - |
| 5 y5 years | - | - | - |
TLX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.6% | +612.7% | ||||
| 5 y | 5-year | -25.6% | +3120.6% | ||||
| alltime | all time | -25.6% | +3120.6% |
Telix Pharmaceuticals Limited CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $7.17 M(-25.6%) | - | - |
| Dec 2022 | $9.63 M(+857.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.01 M(+351.9%) | - | - |
| Dec 2020 | $222.50 K(-31.6%) | - | - |
| Dec 2019 | $325.30 K | - | - |
FAQ
- What is Telix Pharmaceuticals Limited annual capital expenditures?
- What is the all time high annual CAPEX for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited annual CAPEX year-on-year change?
What is Telix Pharmaceuticals Limited annual capital expenditures?
The current annual CAPEX of TLX is $7.17 M
What is the all time high annual CAPEX for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high annual capital expenditures is $9.63 M
What is Telix Pharmaceuticals Limited annual CAPEX year-on-year change?
Over the past year, TLX annual capital expenditures has changed by -$2.46 M (-25.57%)